Reaction Details Report a problem with these data
Target
Tyrosine-protein kinase BTK
Ligand
BDBM350141
Substrate
n/a
Meas. Tech.
Btk Enzyme Activity Assay
IC50
7.00±n/a nM
Citation
 Liu, J; Kozlowski, JA; Andresen, BM; Boga, SB; Gao, X; Guiadeen, DG; Cai, J; Liu, S; Wang, D; Wu, H; Yang, C Tertiary alcohol imidazopyrazine BTK inhibitors US Patent  US10208047 Publication Date 2/19/2019 
Target
Name:
Tyrosine-protein kinase BTK
Synonyms:
AGMX1 | ATK | Agammaglobulinaemia tyrosine kinase | Agammaglobulinemia tyrosine kinase | B cell progenitor kinase | B-cell progenitor kinase | BPK | BTK | BTK_HUMAN | Bruton tyrosine kinase | Tyrosine Kinase BTK | Tyrosine-protein kinase (BTK) | Tyrosine-protein kinase BTK (BTK)
Type:
Enzyme
Mol. Mass.:
76289.95
Organism:
Homo sapiens (Human)
Description:
Q06187
Residue:
659
Sequence:
MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSSHRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES
  
Inhibitor
Name:
BDBM350141
Synonyms:
5-[8-amino-1-(4-{(1R)-1- hydroxy-1-[3- (trifluoromethyl)phenyl] ethyl}phenyl)imidazo[1,5- a]pyrazin-3- yl]bicyclo[3.2.2]nonane-1- carboxylic acid | US10208047, Example 9
Type:
Small organic molecule
Emp. Form.:
C31H31F3N4O3
Mol. Mass.:
564.598
SMILES:
C[C@@](O)(c1ccc(cc1)-c1nc(n2ccnc(N)c12)C12CCC(CC1)(CCC2)C(O)=O)c1cccc(c1)C(F)(F)F |r,wU:1.0,wD:1.1,(3.86,5.48,;2.38,5.88,;3.47,6.97,;1.98,4.4,;3.07,3.31,;2.67,1.82,;1.18,1.42,;.09,2.51,;.49,4,;.78,-.07,;1.69,-1.31,;.78,-2.56,;-.68,-2.08,;-2.02,-2.85,;-3.35,-2.08,;-3.35,-.54,;-2.02,.23,;-2.02,1.77,;-.68,-.54,;1.55,-3.89,;.22,-4.66,;.22,-6.2,;1.55,-6.97,;2.89,-6.2,;2.89,-4.66,;3.64,-6.41,;3.64,-5.16,;2.91,-3.89,;1.15,-8.46,;-.33,-8.86,;2.24,-9.55,;1.29,6.97,;1.69,8.46,;.6,9.55,;-.89,9.15,;-1.29,7.66,;-.2,6.57,;-2.78,7.26,;-3.86,8.35,;-3.17,5.78,;-2.78,8.8,)|
Structure:
Search PDB for entries with ligand similarity: